Bringing the fundamentals into focus…
Back to Collegium Pharmaceutical, Inc.
How Collegium Pharmaceutical, Inc. stacks up
COLL · against 1,327 other Healthcare companies
Overall
64/ 100
Near the top of its peers.
Ranked #281 of 1,328 · scores higher than 77% of peers
Bars: peers in each 10-point band of the overall score261 peers with an overall score of 60–69, including COLL · Click a bar to see the companies
The four scores behind it
Overall = average of valuation, growth, profitability and safety percentile (categories without data are skipped)Ranking by overall score
Top 5 and the companies ranked around COLL| Rank | Company | Market cap | Overall | Valuation | Growth | Profitability | Risk |
|---|---|---|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | 100 | 0 / 2 | ||
| 2 | 595M USD | 97 | 96 | 98 | 99 | 0 / 2 | |
| 2 | 261M USD | 97 | 93 | — | 98 | 0 / 2 | |
| 4 | 2.1B USD | 96 | 96 | 99 | 93 | 0 / 2 | |
| 4 | 15.6B DKK (≈$2.3B) | 96 | 96 | 99 | 96 | 0 / 2 | |
| 281 | 44.2B JPY (≈$301M) | 64 | 96 | 51 | 77 | 2 / 2 | |
| 281 | 2.4B USD | 64 | 68 | 67 | 70 | 1 / 2 | |
| 281 | 157.8B INR (≈$1.9B) | 64 | 72 | 56 | 64 | 1 / 2 | |
| 281 | 4.6B SEK (≈$456M) | 64 | 56 | 47 | 91 | 1 / 2 | |
| 281 | 773M USD | 64 | 92 | 68 | 92 | 2 / 2 | |
| 281 | 10.6B USD | 64 | 61 | 70 | 73 | 1 / 2 | |
| 281 | 3.4B EUR (≈$3.7B) | 64 | 88 | 61 | 83 | 2 / 2 | |
| 281 | 540.4B BRL (≈$97.3B) | 64 | 83 | 72 | 79 | 2 / 2 | |
| 281 | 5.8B USD | 64 | 93 | 79 | 69 | 2 / 2 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score